Injectsense received Series B funding in April 2019 for development and testing of its sensor enabled digital health system. It is currently engaged in raising funds for Series C. The company also generates revenue from projects with healthcare strategics and solution partners.
To learn more about the company and investment opportunities, please contact
CAUTION - Investigational Device. Limited by Federal law to investigational use.